Study on DRP-104 and Durvalumab Combination for Advanced Fibrolamellar Carcinoma | Clinical Trial

Study on DRP-104 and Durvalumab Combination for Advanced Fibrolamellar Carcinoma | Clinical Trial | Right2Hope